MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 186 filers reported holding MANNKIND CORP in Q3 2014. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $134,000 | +3.1% | 210,098 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $130,000 | -46.7% | 210,098 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $244,000 | -11.6% | 210,098 | +30.0% | 0.00% | 0.0% |
| Q1 2016 | $276,000 | +17.9% | 161,645 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $234,000 | -54.4% | 161,645 | +1.2% | 0.00% | -50.0% |
| Q3 2015 | $513,000 | -43.6% | 159,745 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $909,000 | +4.7% | 159,745 | -4.3% | 0.00% | +33.3% |
| Q1 2015 | $868,000 | -3.9% | 166,979 | -3.6% | 0.00% | -25.0% |
| Q4 2014 | $903,000 | -13.0% | 173,239 | -1.4% | 0.00% | 0.0% |
| Q3 2014 | $1,038,000 | -46.2% | 175,636 | +0.1% | 0.00% | -50.0% |
| Q2 2014 | $1,928,000 | +318.2% | 175,388 | +52.8% | 0.01% | +300.0% |
| Q1 2014 | $461,000 | -23.2% | 114,756 | -0.3% | 0.00% | 0.0% |
| Q4 2013 | $600,000 | -11.0% | 115,105 | -2.7% | 0.00% | -33.3% |
| Q3 2013 | $674,000 | -2.7% | 118,281 | +10.9% | 0.00% | -25.0% |
| Q2 2013 | $693,000 | – | 106,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greywolf Capital Management LP | 7,206,570 | $37,582,000 | 6.66% |
| AYM CAPITAL, LLC | 1,417,300 | $7,392,000 | 5.50% |
| AYM CAPITAL, LLC | 655,000 | $3,416,000 | 2.54% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,810,250 | $9,440,000 | 2.51% |
| Beach Point Capital Management LP | 1,902,100 | $9,919,000 | 2.37% |
| Cohen Capital Management, Inc. | 503,000 | $2,623,000 | 0.68% |
| Tourbillon Capital Partners, L.P. | 3,300,000 | $17,210,000 | 0.46% |
| EQUITEC SPECIALISTS, LLC | 288,700 | $1,504,000 | 0.39% |
| Old West Investment Management, LLC | 116,676 | $608,000 | 0.38% |
| Adamant Biomedical Investments AG | 300,000 | $1,564,000 | 0.37% |